特一药业：公司在药物创新研究方面，持续推行中成药和化学药研发双向并举进行

Core Viewpoint - The company is committed to dual-track research in traditional Chinese medicine (TCM) and chemical drugs, aiming to enhance product quality and market competitiveness through innovation [1] Group 1: Traditional Chinese Medicine (TCM) Development - The company is focusing on the inheritance and development of existing TCM products, conducting clinical and real-world studies for secondary development of key TCM products such as cough tablets, skin disease blood detox pills, and blood sugar-lowering pills [1] - The goal is to grow these TCM products into major categories, enhancing the "Te Yi" brand influence and market competitiveness [1] - The company is actively seizing opportunities in the TCM industry by strengthening collaborations with relevant research institutions to develop innovative TCM drugs [1] Group 2: Chemical Drug Development - The company is conducting integrated innovation research on "active pharmaceutical ingredients + formulations," focusing on cutting-edge research for drugs treating major diseases [1] - The approach involves a synergistic model of developing both formulations and active pharmaceutical ingredients to enhance overall research efficiency [1]